We Engineer Breakthrough Value

When a leading pharmaceutical manufacturer faced unprecedented Medicare drug price negotiations under the Inflation Reduction Act, they turned to Lumanity’s unmatched blend of strategy, evidence, engagement, and technology. Mobilizing over 40 experts across market access, pricing, and HEOR, Lumanity crafted a first-of-its-kind submission strategy—securing a higher Maximum Fair Price than the competition. This landmark success not only safeguarded their blockbuster drug’s value, but also solidified an ongoing strategic partnership.

When the world’s largest pharmaceutical distributor set out to build a competitive Cell and Gene Therapy business — entering the market later than its rivals — speed, differentiation, and precision were non‑negotiable. Partnering with Lumanity, they combined deep CGT market insights with bold creative branding to launch a customer‑tailored go‑to‑market strategy that stands out in a fast‑moving, high‑stakes industry. The result? A business poised not just to compete, but to lead in the next era of advanced therapies.